Back | Next |
home / stock / meip / meip message board
Subject | By | Source | When |
---|---|---|---|
Keeps going up. | kzivann | investorshub | 06/07/2022 2:55:26 PM |
Another nice move. Buy some, sell some, | kzivann | investorshub | 06/07/2022 1:58:57 PM |
Dip but .51 not filled | kzivann | investorshub | 06/06/2022 1:52:19 PM |
Premarket volume. | kzivann | investorshub | 06/06/2022 11:14:26 AM |
MEI Pharma and Kyowa Kirin Report New Clinical | Virgowhiteguy | investorshub | 06/04/2022 8:32:23 PM |
Again. | kzivann | investorshub | 06/03/2022 4:48:40 PM |
Another nice bounce. | kzivann | investorshub | 05/31/2022 4:53:04 PM |
Decent move.. | kzivann | investorshub | 05/05/2022 1:39:38 PM |
Very nice. Can $MEIP breakout? | kzivann | investorshub | 05/02/2022 7:45:52 PM |
Bouncing off new low. | kzivann | investorshub | 05/02/2022 2:33:04 PM |
Nice little run.. | kzivann | investorshub | 04/20/2022 5:02:57 PM |
Good morning $MEIP! In @ .64 | green maschine | investorshub | 04/13/2022 12:49:47 PM |
Nice move. Occasionally lucky. Bought yesterday. | kzivann | investorshub | 04/12/2022 4:16:21 PM |
But there may be hope after avg down | ErnieBilco | investorshub | 04/09/2022 4:35:38 PM |
whytestocks: $MEIP News Article - 5 Penny Stocks To Buy According To Big Money Options Bets Right No | whytestocks | investorshangout | 03/30/2022 5:05:50 PM |
Very very poorly | ErnieBilco | investorshub | 03/30/2022 11:40:53 AM |
Well, How your 98s work out? | Bigstud is here | investorshub | 03/30/2022 9:58:10 AM |
Where is the bottom on this thing? | ErnieBilco | investorshub | 03/29/2022 12:43:30 AM |
Glutton for punishment.. back in @.537 average.. | DD-214 | investorshub | 03/28/2022 10:47:40 PM |
Out @.589, lol that was quick.. ill keep | DD-214 | investorshub | 03/28/2022 4:24:34 PM |
News, Short Squeeze, Breakout and More Instantly...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...
– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping Toxicity – – MEI to Continue Advancing ME-344 via Dev...
MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso, president and chief executive officer of MEI Pharma, will participate in a firesi...